All Stories

  1. Bifidobacterium animalis subsp. lactis BB-12 Primes Epithelial Antiviral Defenses and Restricts Influenza A Virus Replication in Human Intestinal Organoid-Derived Monolayers
  2. IMMUNOREACT 4: Peritumoral Microenvironment Associated with Anastomotic Leaks After Surgery for Rectal Cancer
  3. IMMUNOREACT 13: immune features of healthy rectal mucosa as predictors of invasion risk in stage II rectal cancer
  4. Reply to comments to “IMMUNOREACT 8: Immune markers of local tumor spread in patients undergoing transanal excision for clinically N0 rectal cancer”
  5. Advancing therapeutic frontiers: a pipeline of novel drugs for luminal and perianal Crohn's disease management
  6. Leaving behind a diseased small bowel during surgery for Crohn’s disease: Long-term outcomes
  7. Predictors of urinary tract infection after lower gastrointestinal surgery
  8. IMMUNOREACT 0: Biopsy‐based immune biomarkers as predictors of response to neoadjuvant therapy for rectal cancer—A systematic review and meta‐analysis
  9. Extraintestinal Cancers in Inflammatory Bowel Disease: A Literature Review
  10. IMMUNOREACT 6: weak immune surveillance characterizes early-onset rectal cancer
  11. Role of Immune Microenvironment in Pancreatic Ductal Adenocarcinoma: Could It Be Considered a Predictor of Prognosis?
  12. Collagen VI promotes recovery from colitis by inducing lymphangiogenesis and drainage of inflammatory cells
  13. The impact of COVID-19 pandemic on access to medical services and its consequences on emergency surgery
  14. Treatment and Prognosis of Fibrolamellar Hepatocellular Carcinoma: a Systematic Review of the Recent Literature and Meta-analysis
  15. Impact of DNA mismatch repair proteins deficiency on number and ratio of lymph nodal metastases in colorectal adenocarcinoma
  16. IMMUNOREACT 5: female patients with rectal cancer have better immune editing mechanisms than male patients – a cohort study
  17. Vedolizumab is superior to infliximab in biologic naïve patients with ulcerative colitis
  18. Rectal Sparing Approaches after Neoadjuvant Treatment for Rectal Cancer: A Systematic Review and Meta-Analysis Comparing Local Excision and Watch and Wait
  19. Tumor immune microenvironment in therapy‐naive esophageal adenocarcinoma could predict the nodal status
  20. Chemoradiation vs. local excision in the management of early squamous cell carcinoma of the anus: a systematic review
  21. Molecular Determinants of Peritoneal Dissemination in Gastric Adenocarcinoma
  22. Validation of the Padova Prognostic Score for Colitis in Predicting Long-Term Outcome After Restorative Proctocolectomy
  23. Biohumoral Predictors of Advanced Pancreatic Carcinoma Not Shown at Pre-operative Imaging
  24. Prognostic significance of additional histologic features for subclassification of pathological T3 colon cancer
  25. Metachronous colorectal cancer have a similar microsatellite instability frequency but a lower infiltration of lymphomononuclear cells than primary lesions
  26. Reply to: “The strength of a randomized controlled trial lies in its design—randomization”
  27. Discrimination Toward Women in Surgery
  28. Colorectal cancer development is affected by the ECM molecule EMILIN-2 hinging on macrophage polarization via the TLR-4/MyD88 pathway
  29. Could Total Neoadjuvant Therapy Followed by Surgical Resection Be the New Standard of Care in Pancreatic Cancer? A Systematic Review and Meta-Analysis
  30. Impact on Quality of Life of Seton Placing in Perianal Crohn's Disease
  31. Crohn’s Disease-Related Stoma Complications and Their Impact on Postsurgical Course
  32. Totally Implantable Venous Access Devices: A Randomized Controlled Trial on the Effect of Psychological Support on Quality of Life and Body Image (BI-PORT)
  33. Current Understanding of Epigenetics Driven Therapeutic Strategies in Colorectal Cancer Management
  34. How a modified Nissen procedure works: a mechanistic study using intraoperative esophageal high-resolution manometry
  35. Epstein-Barr virus associated gastric dysplasia: a new rare entity?
  36. Sarcopenia, severe anxiety and increased C-reactive protein are associated with severe fatigue in patients with inflammatory bowel diseases
  37. Mortality from esophagectomy for esophageal cancer across low, middle, and high-income countries: An international cohort study
  38. Persistent Herpes Simplex Virus Type 1 Infection of Enteric Neurons Triggers CD8+ T Cell Response and Gastrointestinal Neuromuscular Dysfunction
  39. MLH1 Deficiency Down-Regulates TLR4 Expression in Sporadic Colorectal Cancer
  40. Prevention Strategies for Esophageal Cancer—An Expert Review
  41. Moderately differentiated esophageal squamous cell carcinoma has a poor prognosis after neoadjuvant chemoradiotherapy
  42. Esophageal squamous cell carcinoma metachronous to head and neck cancers
  43. CD80 expression is upregulated by TP53 activation in human cancer epithelial cells
  44. Oligometastatic Pancreatic Cancer to the Liver in the Era of Neoadjuvant Chemotherapy: Which Role for Conversion Surgery? A Systematic Review and Meta-Analysis
  45. Laparoscopic Ventral Rectopexy for Obstructed Defecation: Functional Results and Quality of Life
  46. Reactive Oxygen Species and Antitumor Immunity—From Surveillance to Evasion
  47. QOLEC2: a randomized controlled trial on nutritional and respiratory counseling after esophagectomy for cancer
  48. Correction to: Inflammatory bowel disease position statement of the Italian Society of Colorectal Surgery (SICCR): ulcerative colitis
  49. SARS-CoV-2 containment in complex surgical units during the COVID-19 pandemic
  50. Lasting Symptoms After Esophageal Resection (LASER)
  51. Circulating microRNA expression profiling revealed miR-92a-3p as a novel biomarker of Barrett’s carcinogenesis
  52. Inflammatory bowel disease position statement of the Italian Society of Colorectal Surgery (SICCR): ulcerative colitis
  53. Can Vascular Endothelial Growth Factors and CD34 Expression Implement NICE (Narrow-Band Imaging International Colorectal Endoscopic) Classification in Colorectal Polypoid Lesion Diagnosis?
  54. Immune surveillance activation after neoadjuvant therapy for esophageal adenocarcinoma and complete response
  55. PD-L1 expression in gastroesophageal dysplastic lesions
  56. Inflammatory Bowel Disease Therapies Adversely Affect Fertility in Men- A Systematic Review and Meta-analysis
  57. Interferon-Gamma and Tumor Necrosis Factor-Related Weak Inducer of Apoptosis Expression in Neoangiogenesis in Colorectal Polypoid Lesions
  58. Correction to: Assessment of intratumor immune-microenvironment in colorectal cancers with extranodal extension of nodal metastases
  59. Prognostic role of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with midgut neuroendocrine tumors undergoing resective surgery
  60. PD‐L1 expression, CD8+ and CD4+ lymphocyte rate are predictive of pathological complete response after neoadjuvant chemoradiotherapy for squamous cell cancer of the thoracic esophagus
  61. Pathological Tumor Regression Grade Classifications in Gastrointestinal Cancers: Role on Patients’ Prognosis
  62. Diffusion-weighted magnetic resonance for assessing fibrosis in Crohn’s disease
  63. CD80 expression promotes immune surveillance in Barrett’s metaplasia
  64. Neutrophil-to-lymphocyte ratio as prognostic marker in esophageal cancer: a systematic review and meta-analysis
  65. Weak Cytotoxic T Cells Activation Predicts Low-Grade Dysplasia Persistence in Ulcerative Colitis
  66. Claudin-18 expression in oesophagogastric adenocarcinomas: a tissue microarray study of 523 molecularly profiled cases
  67. Epithelial CD80 promotes immune surveillance of colonic preneoplastic lesions and its expression is increased by oxidative stress through STAT3 in colon cancer cells
  68. S quamous cell carcinoma antigen 1 is associated to poor prognosis in esophageal cancer through immune surveillance impairment and reduced chemosensitivity
  69. A Case of Carcinosarcoma of the Gastroesophageal Junction With Neuroendocrine and Chondroid Differentiation
  70. Psychological support of esophageal cancer patient?
  71. Human papillomavirus infection is not involved in esophageal verrucous carcinoma
  72. Electrochemotherapy – Emerging applications technical advances, new indications, combined approaches, and multi-institutional collaboration
  73. miR-224 Is Significantly Upregulated and Targets Caspase-3 and Caspase-7 During Colorectal Carcinogenesis
  74. Cholecystectomy during esophagectomy is safe but unnecessary
  75. Herpes Simplex Virus Type 1 Engages Toll Like Receptor 2 to Recruit Macrophages During Infection of Enteric Neurons
  76. Assessment of intratumor immune-microenvironment in colorectal cancers with extranodal extension of nodal metastases
  77. Esophageal cancer patients’ information management: cross-cultural differences between Dutch and Italian patients in perceived quality of provided oncological information
  78. Correction: Effects of immune suppression for transplantation on inflammatory colorectal cancer progression
  79. Effects of immune suppression for transplantation on inflammatory colorectal cancer progression
  80. Antibacterial efficacy and mechanisms of action of low power atmospheric pressure cold plasma: membrane permeability, biofilm penetration and antimicrobial sensitization
  81. Time to diagnosis in esophageal cancer: a cohort study
  82. Herpes Simplex Virus Type 1 Infects Enteric Neurons and Triggers Gut Dysfunction via Macrophage Recruitment
  83. Long-term quality of life after esophagectomy with gastric pull-up
  84. Esophageal Cancer Clinical Presentation
  85. Potential curability and perception of received information in esophageal cancer patients
  86. Esophageal adenocarcinoma microenvironment: Peritumoral adipose tissue effects associated with chemoresistance
  87. Immunonutrition before esophagectomy: Impact on immune surveillance mechanisms
  88. miR-194 as predictive biomarker of responsiveness to neoadjuvant chemoradiotherapy in patients with locally advanced rectal adenocarcinoma
  89. A systematic review of segmental vs subtotal colectomy and subtotal colectomy vs total proctocolectomy for colonic Crohn's disease
  90. Colorectal cancer in the young: a possible role for immune surveillance?
  91. Angiogenesis inhibitors and symptomatic anal ulcers in metastatic colorectal cancer patients
  92. Randomized clinical trial of psychological support and sleep adjuvant measures for postoperative sleep disturbance in patients undergoing oesophagectomy
  93. PD-L1 overexpression in ampulla of Vater carcinoma and its pre-invasive lesions
  94. Angiogenesis inhibitor bevacizumab and symptomatic anal ulcers in metastatic colorectal cancer patients: A single center experience.
  95. Nodal skip metastasis in thoracic esophageal squamous cell carcinoma: a cohort study
  96. The molecular landscape of colitis-associated carcinogenesis
  97. Colorectal polypoid lesions and expression of vascular endothelial growth factor in a consecutive series of endoscopic and surgical patients
  98. Early miR-223 Upregulation in Gastroesophageal Carcinogenesis
  99. Squamous cell carcinoma antigen (SCCA) is up-regulated during Barrett’s carcinogenesis and predicts esophageal adenocarcinoma resistance to neoadjuvant chemotherapy
  100. Hedgehog signaling in colorectal cancer: a spiny issue gets smoothened
  101. Applied investigation of person-specific and context-specific factors on postoperative recovery and clinical outcomes of patients undergoing gastrointestinal cancer surgery: multicentre European study
  102. CD80 down-regulation is associated to aberrant DNA methylation in non-inflammatory colon carcinogenesis
  103. Synchronous polyps predict metachronous colorectal lesions after curative resection of colorectal cancer
  104. Mo1760 Crohn's Disease Recurrence After Ileocolonic Resection: High Expression of TLR2 and TLR4 is Associated to Prolonged Disease Free Interval
  105. Su1750 Crohn's Disease Recurrence After Ileocolonic Resection: Higher BDNF Levels in Healthy Ileum Is Associated to a Longer Recurrence-Free Interval
  106. Mo1221 Esophageal Cancer Patients Management: Cross-Cultural Differences Between Dutch and Italian Patients in Perceived Quality of Provided Oncological Information
  107. Su1153 Information Providing to Patients With Esophageal Cancer in a Tertiary Referral Center
  108. Tu1863 TLR4 and MyD88 and Mismatch Repair Genes in Colorectal Cancer
  109. Tu1867 The Capability of Antigen Presentation of Colonic Epithelial Cells Is Essential to Activate an Effective CD8 Response During the Early Phases of the Carcinogenic Progression
  110. Aberrant gene methylation in non-neoplastic mucosa as a predictive marker of ulcerative colitis-associated CRC
  111. Impact of esophagectomy for cancer on patients' occupational status
  112. The Role of Surgery in Patients With a Complete Clinical Response After Chemoradiation for Esophageal Cancer
  113. Mismatch repair gene defects in sporadic colorectal cancer enhance immune surveillance
  114. Hybrid minimally invasive esophagectomy for cancer: impact on postoperative inflammatory and nutritional status
  115. Health related quality of life after oesophagectomy: elderly patients refer similar eating and swallowing difficulties than younger patients
  116. TAK1 is a key modulator of the profibrogenic phenotype of human ileal myofibroblasts in Crohn's disease
  117. Postoperative outcome after oesophagectomy for cancer: Nutritional status is the missing ring in the current prognostic scores
  118. Esophagectomy in elderly patients: which is the best prognostic score?
  119. Esophageal adenocarcinoma and obesity: peritumoral adipose tissue plays a role in lymph node invasion
  120. Systematic review of surgical treatment of subclinical Cushing's syndrome
  121. Palliative therapy for esophageal cancer: laser therapy alone is associated with a better functional outcome
  122. CD80-CD28 signaling controls the progression of inflammatory colorectal carcinogenesis
  123. Intestinal Surgery for Crohn's Disease: Role of Preoperative Therapy in Postoperative Outcome
  124. The effects of acupuncture after thyroid surgery: A randomized, controlled trial
  125. Complications after surgery for colorectal cancer affect quality of life and surgeon-patient relationship
  126. Role of Proton Pump Inhibitor on Esophageal Carcinogenesis and Pancreatic Acinar Cell Metaplasia Development: An Experimental In Vivo Study
  127. Oesophageal cancer: assessment of tumour response to chemoradiotherapy with tridimensional CT
  128. Esophageal Cancer Management: Preoperative CA19.9 and CEA Serum Levels May Identify Occult Advanced Adenocarcinoma
  129. Diffusion-Weighted Magnetic Resonance for Assessing Ileal Crohnʼs Disease Activity
  130. Detailed study of the K ± → π 0 π 0 e ± ν (K e4 00 ) decay properties
  131. MGMT promoter methylation and correlation with protein expression in primary central nervous system lymphoma
  132. Totally implantable venous access devices: retrospective analysis of different insertion techniques and predictors of complications in 796 devices implanted in a single institution
  133. The effect of tacrolimus compared with betamethasone valerate on the skin barrier in volunteers with quiescent atopic dermatitis
  134. Inflammatory colonic carcinogenesis: A review on pathogenesis and immunosurveillance mechanisms in ulcerative colitis
  135. Relationship between pouch microbiota and pouchitis following restorative proctocolectomy for ulcerative colitis
  136. Sleep disturbances and quality of life in postoperative management after esophagectomy for esophageal cancer
  137. Minimally invasive treatment of peristomal metastases from gastric cancer at an ileostomy site by electrochemotherapy
  138. Minimally invasive surgery for esophageal cancer: a review on sentinel node concept
  139. Complete Clinical Response After Neoadjuvant Chemoradiotherapy for Squamous Cell Cancer of the Thoracic Oesophagus: Is Surgery Always Necessary?
  140. The Effect of Dichotomizing Age in Outcomes Assessment of the Surgical Management of Esophageal Cancer
  141. Minimally invasive surgery for colorectal cancer: quality of life and satisfaction with care in elderly patients
  142. More information about the pattern of lymphatic spread could improve the effectiveness of surgery for esophageal cancer
  143. Low Perioperative Serum Prealbumin Predicts Early Recurrence After Curative Pulmonary Resection for Non-Small-Cell Lung Cancer
  144. Health-Related Quality of Life in Patients with Oesophageal Cancer: Analysis at Different Steps of the Treatment Pathway
  145. Mucosal immune environment in colonic carcinogenesis: CD80 expression is associated to oxidative DNA damage and TLR4–NFκB signalling
  146. PDCD4/miR-21 dysregulation in inflammatory bowel disease-associated carcinogenesis
  147. What is the optimal management of dysphagia in metastatic esophageal cancer?
  148. Does Obesity Affect Outcomes in Patients Undergoing Esophagectomy for Cancer? Comments on a Meta-analysis
  149. Overweight Patients Operated on for Cancer of the Esophagus Survive Longer than Normal-Weight Patients
  150. Intraoperative Blood Transfusion Contributes to Decreased Long-Term Survival of Patients with Esophageal Cancer: Comments on Regression Model Estimation
  151. Cost-Effectiveness Analysis of Postoperative Surveillance Protocols Following Radical Surgery for Colorectal Cancer
  152. Innate Immune Environment in Ileal Pouch Mucosa: α5 Defensin Up-regulation as Predictor of Chronic/Relapsing Pouchitis
  153. TLR2 and TLR4 Up-regulation and Colonization of the Ileal Mucosa by Clostridiaceae spp. in Chronic/Relapsing Pouchitis
  154. Magnetic Resonance Enterography for Crohn’s Disease: What the Surgeon Can Take Home
  155. Relationship between mucosa-associated microbiota and inflammatory parameters in the ileal pouch after restorative proctocolectomy for ulcerative colitis
  156. Nodal Metastasis From Locally Advanced Esophageal Cancer: How Neoadjuvant Therapy Modifies Their Frequency and Distribution
  157. Complete Response After Neoadjuvant Chemoradiotherapy for Cancer of the Thoracic Esophagus and Esophago-Gastric Junction: Prognostic Significance and Clinical Implications
  158. Mucosal Immune Environment in Colonic Carcinogenesis: T-Cell Activation in Ulcerative Colitis and Dysplasia
  159. Mucosal immune environment in colonic carcinogenesis: CD80 up-regulation in colonic dysplasia in ulcerative colitis
  160. Long-term health-related quality of life after minimally invasive surgery for diverticular disease
  161. New measurement of the K±→π±
  162. Systematic review of health-related quality of life after esophagectomy for esophageal cancer
  163. Antioxidative potential of a combined therapy of anti TNFα and Zn acetate in experimental colitis
  164. Perianal Crohn’s disease: Is there something new?
  165. Quality of life in patients with esophageal stenting for the palliation of malignant dysphagia
  166. A systematic review on advancement flaps for rectovaginal fistula in Crohn’s disease: transrectal vs transvaginal approach
  167. Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
  168. Diode laser treatment of Barrett’s esophagus: long-term results
  169. A systematic review of diagnostic procedures to detect midgut neuroendocrine tumors
  170. Rectal Administration of Lactobacillus casei DG Modifies Flora Composition and Toll-Like Receptor Expression in Colonic Mucosa of Patients with Mild Ulcerative Colitis
  171. Clinical Presentation and Diagnosis of Intestinal Adenocarcinoma in Crohn’s Disease: Analysis of Clinical Predictors and of the Life-Time Risk
  172. Measurement of the direct emission and interference terms and search for CP violation in the decay K ±→π ± π 0 γ
  173. Ileal neuroendocrine carcinoma following restorative proctocolectomy for colonic adenocarcinoma in Crohn's disease
  174. Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
  175. P.60 HOMING SIGNALS OF ENDOTHELIAL PROGENITORS CELLS IN IBD PATIENTS
  176. Stapled haemorrhoidopexy: extent of tissue excision and clinical implications in the early postoperative period
  177. Deep Venous Thrombosis After Surgery for Inflammatory Bowel Disease: Is Standard Dose Low Molecular Weight Heparin Prophylaxis Enough?
  178. Quality of life after surgery of the alimentary tract
  179. Health related quality of life after surgery for colonic diverticular disease
  180. Subclinical Intestinal Inflammation in Patients with Crohn’s Disease Following Bowel Resection: A Smoldering Fire
  181. Intestinal Surgery for Crohn’s Disease: Predictors of Recovery, Quality of Life, and Costs
  182. The hostile neck does not increase the risk of carotid endarterectomy
  183. Reduced Endothelial Progenitor Cell Number and Function in Inflammatory Bowel Disease: A Possible Link to the Pathogenesis
  184. Restorative proctocolectomy for inflammatory bowel disease
  185. Diverting loop ileostomy after restorative proctocolectomy: predictors of poor outcome and poor quality of life
  186. TGF-β1 and IGF-1 Production and Recurrence of Crohn's Disease After Ileo-Colonic Resection
  187. Plasma lipids and inflammation in active inflammatory bowel diseases
  188. Inflammatory Fibroid Polyp Causing Intestinal Obstruction following Restorative Proctocolectomy for Ulcerative Colitis
  189. Validation of an English Version of the Padova Quality of Life Instrument to Assess Quality of Life Following Ileal Pouch Anal Anastomosis
  190. Cytokine network in rectal mucosa in perianal Crohnʼs disease: Relations with inflammatory parameters and need for surgery
  191. A systematic review on the clinical diagnosis of gastrointestinal stromal tumors
  192. Health-Related Quality of Life after Colonic Resection for Diverticular Disease: Long-term Results
  193. TGF-β1 and IGF-1 and Anastomotic Recurrence of Crohn’s Disease After Ileo-Colonic Resection
  194. Double contrast small-bowel radiography in the preoperative assessment of Crohn’s disease: Is it still useful?
  195. Lipid and phospholipid profile after bowel resection for Crohn’s disease
  196. Minimally invasive surgery for colorectal cancer: quality of life, body image, cosmesis, and functional results
  197. PA.165 CYTOKINE NETWORK IN RECTAL MUCOSA IN PERIANAL CROHN'S DISEASE: RELATIONS WITH INFLAMMATORY PARAMETERS AND NEED FOR SURGERY
  198. PA.59 HEALTH RELATED QUALITY OF LIFE AND CLINICAL OUTCOME AFTER COLONIC RESECTION FOR DIVERTICULAR DISEASE: LONG-TERM RESULTS
  199. OC3.03.9 LONG TERM OUTCOME AND QUALITY OF LIFE AFTER RESTORATIVE PROCTOCOLECTOMY IN A COHORT OF 955 CANADIAN PATIENTS
  200. PA.175 RESTORATIVE PROCTOCOLECTOMY FOR INFLAMMATORY BOWEL DISEASE: IS PRE-OPERATIVE DIAGNOSIS A PREDICTOR OF LONG TERM OUTCOME AND HEALTH RELATED QUALITY OF LIFE?
  201. New high statistics measurement of Ke4 decay form factors and ππ scattering phase shifts
  202. B1a Lymphocytesʼ expression in the rectum of ulcerative colitis patients
  203. First observation and measurement of the decay K±→π±<...
  204. Gastrointestinal telangiectasia: a study by EGD, colonoscopy, and capsule endoscopy in 75 patients
  205. Endoscopic Dilation of Benign Esophageal Strictures in a Surgical Unit
  206. Restorative Proctocolectomy for Ulcerative Colitis: Impact on Lipid Metabolism and Adipose Tissue and Serum Fatty Acids
  207. Fecal Lactoferrin and Calprotectin After Ileocolonic Resection for Crohnʼs Disease
  208. Surgical predictors of recurrence of Crohn’s disease after ileocolonic resection
  209. Enzymes in feces: Useful markers of chronic inflammatory bowel disease
  210. Health-Related Quality of Life after Ileocolonic Resection for Crohnʼs Disease: Long-term Results
  211. B1a lymphocytes in ulcerative colitis
  212. The P326 (NA48/3) Gigatracker: Requirements and design concept
  213. Adenocarcinoma after restorative proctocolectomy for cancer in ulcerative colitis
  214. Quality of Life After Restorative Proctocolectomy for Ulcerative Colitis
  215. Cytokine Network in Chronic Perianal Crohn’s Disease and Indeterminate Colitis After Colectomy
  216. Decision making for metastatic diseases to the ovaries from colorectal cancer
  217. Ovarian metastasis from colorectal cancer: Prognostic value of radical oophorectomy
  218. Systematic review of dysplasia after restorative proctocolectomy for ulcerative colitis
  219. Rod in loop ileostomy: just an insignificant detail for ileostomy-related complications?
  220. Expression of costimulatory molecule CD80 in colonic dysplasia in ulcerative colitis: an immunosurveillance mechanism against colorectal cancer?
  221. Are frozen sections useful and cost-effective in the era of intraoperative qPTH assays?
  222. A Gastrocolic Fistula in Crohn’s Disease
  223. Ileostomy for constipation: long-term postoperative outcome
  224. Unusual cause of small bowel perforation: metastasis of a subcutaneous angiosarcoma of the head
  225. Persistence of high CD40 and CD40L expression after restorative proctocolectomy for ulcerative colitis
  226. Early Surgery for the Treatment of Toxic Megacolon
  227. Effects of iron manipulation on trace elements level in a model of colitis in rats
  228. The Role of Costimulatory Molecules CD80 and CD86 and IFNγ in the Pathogenesis of Ulcerative Colitis
  229. Minimally Invasive Management of Crohn's Disease Complicated by Ureteral Stenosis
  230. Observation of the rare decay KS→π0
  231. Measurement of the branching ratio and form factors for the decay KL→π±π0e∓νe(ν̄e)
  232. The drift chamber electronics for the NA48 experiment
  233. Effects of iron deprivation or chelation on DNA damage in experimental colitis
  234. Health-related quality of life after restorative proctocolectomy for ulcerative colitis: Long-term results
  235. A new drift chamber TDC readout for the high intensity program of the NA48 experiment
  236. Observation of the rare decay KS→π0e+e−
  237. Effects of iron manipulation on trace elements status in DNBS-induced colitis
  238. The drift chamber electronics for the NA48 experiment
  239. The role of CD40 in ulcerative colitis: histochemical analysis and clinical correlation
  240. Life table analysis of hernia following end colostomy construction